Velcade, Doxil and Thalidomide (VDT) is an effective salvage regimen for patients with relapsed and refractory multiple myeloma

被引：22
作者：
Chanan-Khan, A [1 ]
Miller, KC [1 ]
机构：
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
来源：
LEUKEMIA & LYMPHOMA | 2005年 / 46卷 / 07期
关键词：
D O I：
10.1080/10428190500097086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1103 / 1104
页数：2
相关论文
共 9 条
  • [1] Thalidomide and dexamethasone for resistant multiple myeloma
    Anagnostopoulos, A
    Weber, D
    Rankin, K
    Delasalle, K
    Alexanian, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) : 768 - 771
  • [2] Moving disease biology from the lab to the clinic
    Anderson, KC
    [J]. CANCER, 2003, 97 (03) : 796 - 801
  • [3] The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review
    Hahn, T
    Wingard, JR
    Anderson, KC
    Bensinger, WI
    Berenson, JR
    Brozeit, G
    Carver, JR
    Kyle, RA
    McCarthy, PL
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (01) : 4 - 37
  • [4] Novel therapeutic approaches for multiple myeloma
    Hideshima, T
    Richardson, P
    Anderson, KC
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 194 (01) : 164 - 176
  • [5] Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
    Hideshima, T
    Akiyama, M
    Hayashi, T
    Richardson, P
    Schlossman, R
    Chauhan, D
    Anderson, KC
    [J]. BLOOD, 2003, 101 (02) : 703 - 705
  • [6] Orlowski Robert Z, 2004, Expert Rev Anticancer Ther, V4, P171, DOI 10.1586/14737140.4.2.171
  • [7] Advances in the treatment of multiple myeloma: The role of thalidomide
    Ribas, C
    Colleoni, GWB
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 291 - 298
  • [8] A phase 2 study of bortezomib in relapsed, refractory myeloma
    Richardson, PG
    Barlogie, B
    Berenson, J
    Singhal, S
    Jagannath, S
    Irwin, D
    Rajkumar, SV
    Srkalovic, G
    Alsina, M
    Alexanian, R
    Siegel, D
    Orlowski, RZ
    Kuter, D
    Limentani, SA
    Lee, S
    Hideshima, T
    Esseltine, DL
    Kauffman, M
    Adams, J
    Schenkein, DP
    Anderson, KC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) : 2609 - 2617
  • [9] Antitumor activity of thalidomide in refractory multiple myeloma.
    Singhal, S
    Mehta, J
    Desikan, R
    Ayers, D
    Roberson, P
    Eddlemon, P
    Munshi, N
    Anaissie, E
    Wilson, C
    Dhodapkar, M
    Zeldis, J
    Barlogie, B
    Siegel, D
    Crowley, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) : 1565 - 1571
1